![Mary Pinder-Schenck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mary Pinder-Schenck
Chief Tech/Sci/R&D Officer at
REVOLUTION MEDICINES, INC.
Profile
Mary Pinder-Schenck currently works at Revolution Medicines, Inc., as Senior Vice President-Medical Affairs from 2024.
Dr. Pinder-Schenck also formerly worked at National Comprehensive Cancer Network, Inc., as Member and Kite Pharma, Inc., as Head-US Medical Affairs.
Dr. Pinder-Schenck received her undergraduate degree from Wellesley College and doctorate degree from Stanford University School of Medicine.
Mary Pinder-Schenck active positions
| Companies | Position | Start |
|---|---|---|
| REVOLUTION MEDICINES, INC. | Chief Tech/Sci/R&D Officer | 2024-06-30 |
Former positions of Mary Pinder-Schenck
| Companies | Position | End |
|---|---|---|
National Comprehensive Cancer Network, Inc.
 National Comprehensive Cancer Network, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services to fight against cancer | Corporate Officer/Principal | - |
| KITE PHARMA INC | Corporate Officer/Principal | - |
Education of Mary Pinder-Schenck
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
23
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Wellesley College
 Wellesley College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Comprehensive Cancer Network, Inc.
National Comprehensive Cancer Network, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services to fight against cancer | Commercial Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Revolution Medicines, Inc.
 Revolution Medicines, Inc. Pharmaceuticals: OtherHealth Technology Develops new therapies derived from natural products | Health Technology |
- Stock Market
- Insiders
- Mary Pinder-Schenck
